MedPath

Comparsion of D2 verus D3 surgical procedure outcome in locally advanced gastric cancer patients following perioperative chemotherapy

Phase 3
Conditions
Health Condition 1: null- Gastric Cancer
Registration Number
CTRI/2013/08/003882
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
287
Inclusion Criteria

ECOG performance status of 0 â?? 1 in patients deemed fit to undergo surgery at the pre-anaesthetic check

-Histologically proven gastric adenocarcinoma

-No evidence of distant metastases, or locally advanced inoperable disease, as evaluated by computed tomography, chest radiography, ultrasonography, and / or laparotomy

-Patient able to provide valid informed consent

-Patient completed at least 1 cycle of neoadjuvant chemotherapy

Exclusion Criteria

Presence of any 1 of the following:

-Previous or concomitant other cancer

-Primary Oesophageal involvement extending to the stomach

-Distant hepatic / extrahepatic disease discovered on laparotomy

-Gross local disease in the porta precluding a curative resection

-Patient did not consent for the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary endpoint:Overall Survival <br/ ><br>Timepoint: date of diagnosis to Date of death or last follow-up
Secondary Outcome Measures
NameTimeMethod
Disease-free survival <br/ ><br>Timepoint: date of diagnosis to date of death /recurrence
© Copyright 2025. All Rights Reserved by MedPath